Cargando…
Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure
BACKGROUND: Non-pharmaceutical interventions (NPIs) are recommended for COVID-19 prevention. However, the effectiveness of NPIs in preventing SARS-CoV-2 transmission remains poorly quantified. METHODS: We conducted a test-negative design case-control study enrolling cases (testing positive for SARS-...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903328/ https://www.ncbi.nlm.nih.gov/pubmed/34932817 http://dx.doi.org/10.1093/cid/ciab1040 |
_version_ | 1784664737231929344 |
---|---|
author | Andrejko, Kristin L Pry, Jake Myers, Jennifer F Openshaw, John Watt, James Birkett, Nozomi DeGuzman, Jennifer L Barbaduomo, Camilla M Dong, Zheng N Fang, Anna T Frost, Paulina M Ho, Timothy Javadi, Mahsa H Li, Sophia S Tran, Vivian H Wan, Christine Jain, Seema Lewnard, Joseph A |
author_facet | Andrejko, Kristin L Pry, Jake Myers, Jennifer F Openshaw, John Watt, James Birkett, Nozomi DeGuzman, Jennifer L Barbaduomo, Camilla M Dong, Zheng N Fang, Anna T Frost, Paulina M Ho, Timothy Javadi, Mahsa H Li, Sophia S Tran, Vivian H Wan, Christine Jain, Seema Lewnard, Joseph A |
author_sort | Andrejko, Kristin L |
collection | PubMed |
description | BACKGROUND: Non-pharmaceutical interventions (NPIs) are recommended for COVID-19 prevention. However, the effectiveness of NPIs in preventing SARS-CoV-2 transmission remains poorly quantified. METHODS: We conducted a test-negative design case-control study enrolling cases (testing positive for SARS-CoV-2) and controls (testing negative) with molecular SARS-CoV-2 diagnostic test results reported to California Department of Public Health between 24 February–12 November, 2021. We used conditional logistic regression to estimate adjusted odds ratios (aORs) of case status among participants who reported contact with an individual known or suspected to have been infected with SARS-CoV-2 (“high-risk exposure”) ≤14 days before testing. RESULTS: 751 of 1448 cases (52%) and 255 of 1443 controls (18%) reported high-risk exposures ≤14 days before testing. Adjusted odds of case status were 3.02-fold (95% confidence interval: 1.75–5.22) higher when high-risk exposures occurred with household members (vs. other contacts), 2.10-fold (1.05–4.21) higher when exposures occurred indoors (vs. outdoors only), and 2.15-fold (1.27–3.67) higher when exposures lasted ≥3 hours (vs. shorter durations) among unvaccinated and partially-vaccinated individuals; excess risk associated with such exposures was mitigated among fully-vaccinated individuals. Cases were less likely than controls to report mask usage during high-risk exposures (aOR = 0.50 [0.29–0.85]). The adjusted odds of case status was lower for fully-vaccinated (aOR = 0.25 [0.15–0.43]) participants compared to unvaccinated participants. Benefits of mask usage were greatest among unvaccinated and partially-vaccinated participants, and in interactions involving non-household contacts or interactions occurring without physical contact. CONCLUSIONS: NPIs reduced the likelihood of SARS-CoV-2 infection following high-risk exposure. Vaccine effectiveness was substantial for partially and fully vaccinated persons. |
format | Online Article Text |
id | pubmed-8903328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-89033282022-03-09 Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure Andrejko, Kristin L Pry, Jake Myers, Jennifer F Openshaw, John Watt, James Birkett, Nozomi DeGuzman, Jennifer L Barbaduomo, Camilla M Dong, Zheng N Fang, Anna T Frost, Paulina M Ho, Timothy Javadi, Mahsa H Li, Sophia S Tran, Vivian H Wan, Christine Jain, Seema Lewnard, Joseph A Clin Infect Dis Major Article BACKGROUND: Non-pharmaceutical interventions (NPIs) are recommended for COVID-19 prevention. However, the effectiveness of NPIs in preventing SARS-CoV-2 transmission remains poorly quantified. METHODS: We conducted a test-negative design case-control study enrolling cases (testing positive for SARS-CoV-2) and controls (testing negative) with molecular SARS-CoV-2 diagnostic test results reported to California Department of Public Health between 24 February–12 November, 2021. We used conditional logistic regression to estimate adjusted odds ratios (aORs) of case status among participants who reported contact with an individual known or suspected to have been infected with SARS-CoV-2 (“high-risk exposure”) ≤14 days before testing. RESULTS: 751 of 1448 cases (52%) and 255 of 1443 controls (18%) reported high-risk exposures ≤14 days before testing. Adjusted odds of case status were 3.02-fold (95% confidence interval: 1.75–5.22) higher when high-risk exposures occurred with household members (vs. other contacts), 2.10-fold (1.05–4.21) higher when exposures occurred indoors (vs. outdoors only), and 2.15-fold (1.27–3.67) higher when exposures lasted ≥3 hours (vs. shorter durations) among unvaccinated and partially-vaccinated individuals; excess risk associated with such exposures was mitigated among fully-vaccinated individuals. Cases were less likely than controls to report mask usage during high-risk exposures (aOR = 0.50 [0.29–0.85]). The adjusted odds of case status was lower for fully-vaccinated (aOR = 0.25 [0.15–0.43]) participants compared to unvaccinated participants. Benefits of mask usage were greatest among unvaccinated and partially-vaccinated participants, and in interactions involving non-household contacts or interactions occurring without physical contact. CONCLUSIONS: NPIs reduced the likelihood of SARS-CoV-2 infection following high-risk exposure. Vaccine effectiveness was substantial for partially and fully vaccinated persons. Oxford University Press 2021-12-21 /pmc/articles/PMC8903328/ /pubmed/34932817 http://dx.doi.org/10.1093/cid/ciab1040 Text en © The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_modelThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) |
spellingShingle | Major Article Andrejko, Kristin L Pry, Jake Myers, Jennifer F Openshaw, John Watt, James Birkett, Nozomi DeGuzman, Jennifer L Barbaduomo, Camilla M Dong, Zheng N Fang, Anna T Frost, Paulina M Ho, Timothy Javadi, Mahsa H Li, Sophia S Tran, Vivian H Wan, Christine Jain, Seema Lewnard, Joseph A Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure |
title | Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure |
title_full | Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure |
title_fullStr | Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure |
title_full_unstemmed | Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure |
title_short | Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure |
title_sort | predictors of severe acute respiratory syndrome coronavirus 2 infection following high-risk exposure |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903328/ https://www.ncbi.nlm.nih.gov/pubmed/34932817 http://dx.doi.org/10.1093/cid/ciab1040 |
work_keys_str_mv | AT andrejkokristinl predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT pryjake predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT myersjenniferf predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT openshawjohn predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT wattjames predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT birkettnozomi predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT deguzmanjenniferl predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT barbaduomocamillam predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT dongzhengn predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT fangannat predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT frostpaulinam predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT hotimothy predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT javadimahsah predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT lisophias predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT tranvivianh predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT wanchristine predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT jainseema predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT lewnardjosepha predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure AT predictorsofsevereacuterespiratorysyndromecoronavirus2infectionfollowinghighriskexposure |